Health technology assessment in cancer: A personal view from public health

Norman Robert Waugh

doi:10.1016/j.ejca.2006.08.009

Health technology assessment in cancer: A personal view from public health

Norman Robert Waugh

Research output: Contribution to journal › Article › peer-review

Abstract

Health technology assessment (HTA) poses three main questions: does it work? at what cost? is it worth it? Since funds for health care are always finite, it will not be possible to provide every form of care that may do some good for some people. Hard choices have to be made. HTA is a form of policy analysis that helps decide what to fund and what not to fund. Tensions arise mainly when a new intervention is clinically effective but not cost-effective, usually because the benefit is small and the cost high. (c) 2006 Elsevier Ltd. All rights reserved.

Original language	English
Pages (from-to)	2876-2880
Number of pages	4
Journal	European Journal of Cancer
Volume	42
Issue number	17
DOIs	https://doi.org/10.1016/j.ejca.2006.08.009
Publication status	Published - Nov 2006

Keywords

cancer
health technology assessment
cost-effectiveness
utility
health economics
breast cancer
TRASTUZUMAB

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2006.08.009

Cite this

@article{71c52e20b1914ddc95df492d00018ca8,

title = "Health technology assessment in cancer: A personal view from public health",

abstract = "Health technology assessment (HTA) poses three main questions: does it work? at what cost? is it worth it? Since funds for health care are always finite, it will not be possible to provide every form of care that may do some good for some people. Hard choices have to be made. HTA is a form of policy analysis that helps decide what to fund and what not to fund. Tensions arise mainly when a new intervention is clinically effective but not cost-effective, usually because the benefit is small and the cost high. (c) 2006 Elsevier Ltd. All rights reserved.",

keywords = "cancer, health technology assessment, cost-effectiveness, utility, health economics, breast cancer, TRASTUZUMAB",

author = "Waugh, {Norman Robert}",

year = "2006",

month = nov,

doi = "10.1016/j.ejca.2006.08.009",

language = "English",

volume = "42",

pages = "2876--2880",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "ELSEVIER APPL SCI PUBL LTD",

number = "17",

}

TY - JOUR

T1 - Health technology assessment in cancer

T2 - A personal view from public health

AU - Waugh, Norman Robert

PY - 2006/11

Y1 - 2006/11

N2 - Health technology assessment (HTA) poses three main questions: does it work? at what cost? is it worth it? Since funds for health care are always finite, it will not be possible to provide every form of care that may do some good for some people. Hard choices have to be made. HTA is a form of policy analysis that helps decide what to fund and what not to fund. Tensions arise mainly when a new intervention is clinically effective but not cost-effective, usually because the benefit is small and the cost high. (c) 2006 Elsevier Ltd. All rights reserved.

AB - Health technology assessment (HTA) poses three main questions: does it work? at what cost? is it worth it? Since funds for health care are always finite, it will not be possible to provide every form of care that may do some good for some people. Hard choices have to be made. HTA is a form of policy analysis that helps decide what to fund and what not to fund. Tensions arise mainly when a new intervention is clinically effective but not cost-effective, usually because the benefit is small and the cost high. (c) 2006 Elsevier Ltd. All rights reserved.

KW - cancer

KW - health technology assessment

KW - cost-effectiveness

KW - utility

KW - health economics

KW - breast cancer

KW - TRASTUZUMAB

U2 - 10.1016/j.ejca.2006.08.009

DO - 10.1016/j.ejca.2006.08.009

M3 - Article

SN - 0959-8049

VL - 42

SP - 2876

EP - 2880

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 17

ER -

Health technology assessment in cancer: A personal view from public health

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this